X-120456782-A-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The ENST00000200639.9(LAMP2):c.65-13T>A variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000611 in 949,102 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 11 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000200639.9 splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMP2 | NM_002294.3 | c.65-13T>A | splice_polypyrimidine_tract_variant, intron_variant | ENST00000200639.9 | NP_002285.1 | |||
LAMP2 | NM_001122606.1 | c.65-13T>A | splice_polypyrimidine_tract_variant, intron_variant | NP_001116078.1 | ||||
LAMP2 | NM_013995.2 | c.65-13T>A | splice_polypyrimidine_tract_variant, intron_variant | NP_054701.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMP2 | ENST00000200639.9 | c.65-13T>A | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_002294.3 | ENSP00000200639 | P3 | |||
LAMP2 | ENST00000371335.4 | c.65-13T>A | splice_polypyrimidine_tract_variant, intron_variant | 1 | ENSP00000360386 | A1 | ||||
LAMP2 | ENST00000434600.6 | c.65-13T>A | splice_polypyrimidine_tract_variant, intron_variant | 1 | ENSP00000408411 | A1 | ||||
LAMP2 | ENST00000706600.1 | c.65-13T>A | splice_polypyrimidine_tract_variant, intron_variant | ENSP00000516464 |
Frequencies
GnomAD3 genomes AF: 0.0000358 AC: 4AN: 111709Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33903
GnomAD3 exomes AF: 0.0000221 AC: 3AN: 135641Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 39957
GnomAD4 exome AF: 0.0000645 AC: 54AN: 837393Hom.: 0 Cov.: 14 AF XY: 0.0000520 AC XY: 11AN XY: 211409
GnomAD4 genome AF: 0.0000358 AC: 4AN: 111709Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33903
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 03, 2014 | The c.65-13T>A variant in LAMP2 has not been previously reported in individuals with cardiomyopathy. Data from large population studies are insufficient to asse ss the frequency of this variant. This variant is located in the 3' splice regio n. Computational tools do not suggest an impact to splicing. However, this infor mation is not predictive enough to determine pathogenicity. In summary, the clin ical significance of the c.65-13T>A variant is uncertain. - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 30, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Danon disease Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at